Aug 08, 2025 08:54
INO - Inovio Pharmaceuticals, Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1.7 0.06 (3.82%) | 0.0 (0.0%) | 0.0 (0.0%) | 0.01 (0.57%) | 0.02 (1.18%) | 0.04 (2.32%) | 0.05 (2.78%) | -0.01 (-0.58%) |
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.61
- Diluted EPS:
- -0.61
- Basic P/E:
- -2.8934
- Diluted P/E:
- -2.8934
- RSI(14) 1m:
- 50.0
- VWAP:
- 1.77
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Jul 30, 2025 08:31
May 22, 2024 13:45
May 14, 2024 18:37
May 14, 2024 01:45
May 09, 2024 21:35
May 05, 2024 12:54
Apr 16, 2024 18:17
Apr 16, 2024 12:14
Apr 16, 2024 10:53